ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Lexaria Bioscience Corp
0.0012
0.0000
成交量:
- -
成交額:
- -
市值:
6,125.16
市盈率:
0.00
高:
0.0012
開:
0.0012
低:
0.0012
收:
0.0012
52周最高:
0.4200
52周最低:
0.0009
股本:
510.43萬
流通股本:
510.43萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.6613
淨資產收益率:
-155.23%
總資產收益率:
-82.96%
市淨率:
0.00
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Lexaria Bioscience Corp.盤中異動 早盤股價大跌6.87%
市场透视
·
03/02
Lexaria Bioscience Corp.盤中異動 下午盤股價大漲5.46%報0.664美元
市场透视
·
02/26
Lexaria Bioscience Corp.盤中異動 下午盤急速跳水7.13%報0.673美元
市场透视
·
02/10
Lexaria Bioscience Corp.盤中異動 股價大跌5.82%
市场透视
·
01/27
Lexaria Bioscience Corp.盤中異動 急速上漲5.00%
市场透视
·
01/22
Lexaria Bioscience Corp.盤中異動 快速拉升6.47%
市场透视
·
01/10
Lexaria Bioscience Corp.盤中異動 早盤股價大跌5.30%報0.515美元
市场透视
·
2025/12/31
Lexaria Bioscience Corp.盤中異動 臨近收盤股價大跌5.78%
市场透视
·
2025/10/11
Lexaria Bioscience Corp.盤中異動 早盤股價大漲5.53%報0.960美元
市场透视
·
2025/10/09
Lexaria Bioscience Corp.盤中異動 下午盤大幅上漲5.28%報1.50美元
市场透视
·
2025/09/26
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LEXXW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LEXXW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXXW\",,,,,undefined,":{"symbol":"LEXXW","market":"US","secType":"STK","nameCN":"Lexaria Bioscience Corp","latestPrice":0.0012,"timestamp":1774468800000,"preClose":0.0012,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":5104300,"shares":5104300,"eps":-0.6613,"marketStatus":"盤後交易","change":0,"latestTime":"03-25 18:36:47 EDT","open":0.0012,"high":0.0012,"low":0.0012,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.6613,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774483200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0012,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXXW\",,,,,undefined,":{"symbol":"LEXXW","floatShares":5104300,"roa":"-82.96%","roe":"-155.23%","lyrEps":0,"shares":5104300,"dividePrice":0,"high":0.0012,"amplitude":0,"preClose":0.0012,"low":0.0012,"week52Low":0.0009,"pbRate":"0.00","psRate":"0.01","week52High":0.42,"institutionHeld":0,"latestPrice":0.0012,"eps":-0.6613,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.6613,"open":0.0012,"prevYearClose":0.0042,"prevWeekClose":0.0012,"prevMonthClose":0.0012,"prevQuarterClose":0.0042,"fiveDayClose":0.0012,"twentyDayClose":0.0012,"sixtyDayClose":0.0068},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LEXXW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LEXXW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LEXXW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LEXXW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616318256","title":"Lexaria Bioscience Corp.盤中異動 早盤股價大跌6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616318256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616318256?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 22:30","pubTimestamp":1772461835,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时30分,Lexaria Bioscience Corp.股票出现波动,股价急速下跌6.87%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体涨幅为0.00%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp 是一家生物技术公司,致力于利用其专利 DehydraTECH 药物输送技术提高活性药物成分的生物利用度。该公司运营一个部门:知识产权许可,通过许可其 DehydraTECH 技术来产生收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222303597a7ae35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222303597a7ae35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0},{"id":"2614050260","title":"Lexaria Bioscience Corp.盤中異動 下午盤股價大漲5.46%報0.664美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614050260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614050260?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 02:02","pubTimestamp":1772042526,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日02时02分,Lexaria Bioscience Corp.股票出现波动,股价急速上涨5.46%。截至发稿,该股报0.664美元/股,成交量6.0168万股,换手率0.24%,振幅5.33%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体跌幅为0.30%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp 是一家生物技术公司,致力于利用其专利 DehydraTECH 药物输送技术提高活性药物成分的生物利用度。该公司运营一个部门:知识产权许可,通过许可其 DehydraTECH 技术来产生收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226020207a71f03a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226020207a71f03a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXX","LEXXW"],"gpt_icon":0},{"id":"2610910476","title":"Lexaria Bioscience Corp.盤中異動 下午盤急速跳水7.13%報0.673美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610910476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610910476?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 03:26","pubTimestamp":1770665160,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日03时26分,Lexaria Bioscience Corp.股票出现异动,股价急速下跌7.13%。截至发稿,该股报0.673美元/股,成交量15.8084万股,换手率0.64%,振幅7.63%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体跌幅为0.46%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp 是一家生物技术公司,致力于利用其专利 DehydraTECH 药物输送技术提高活性药物成分的生物利用度。该公司运营一个部门:知识产权许可,通过许可其 DehydraTECH 技术来产生收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021003260097a5874f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021003260097a5874f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"gpt_icon":0},{"id":"2606732355","title":"Lexaria Bioscience Corp.盤中異動 股價大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606732355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606732355?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 22:50","pubTimestamp":1769525411,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日22时50分,Lexaria Bioscience Corp.股票出现波动,股价急速下挫5.82%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体涨幅为0.92%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp 是一家生物技术公司,致力于利用其专利 DehydraTECH 药物输送技术提高活性药物成分的生物利用度。该公司运营一个部门:知识产权许可,通过许可其 DehydraTECH 技术来产生收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012722501197a3a3ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012722501197a3a3ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXX","LEXXW"],"gpt_icon":0},{"id":"2605641495","title":"Lexaria Bioscience Corp.盤中異動 急速上漲5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605641495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605641495?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 22:42","pubTimestamp":1769092963,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日22时42分,Lexaria Bioscience Corp.股票出现波动,股价快速拉升5.00%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体涨幅为0.43%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp 是一家生物技术公司,致力于利用其专利 DehydraTECH 药物输送技术提高活性药物成分的生物利用度。该公司运营一个部门:知识产权许可,通过许可其 DehydraTECH 技术来产生收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122224244a6a10f4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122224244a6a10f4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0},{"id":"2602309447","title":"Lexaria Bioscience Corp.盤中異動 快速拉升6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602309447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602309447?lang=zh_tw&edition=fundamental","pubTime":"2026-01-10 04:59","pubTimestamp":1767992387,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日04时59分,Lexaria Bioscience Corp.股票出现波动,股价快速拉升6.47%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体涨幅为0.00%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp 是一家生物技术公司,致力于利用其专利 DehydraTECH 药物输送技术提高活性药物成分的生物利用度。该公司运营一个部门:知识产权许可,通过许可其 DehydraTECH 技术来产生收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110045948a4b1ac38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110045948a4b1ac38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"gpt_icon":0},{"id":"2600708017","title":"Lexaria Bioscience Corp.盤中異動 早盤股價大跌5.30%報0.515美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600708017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600708017?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 22:32","pubTimestamp":1767191534,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日22时32分,Lexaria Bioscience Corp.股票出现异动,股价大幅跳水5.30%。截至发稿,该股报0.515美元/股,成交量7523股,换手率0.03%,振幅0.90%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体跌幅为0.10%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp 是一家生物技术公司,致力于利用其专利 DehydraTECH 药物输送技术提高活性药物成分的生物利用度。该公司运营一个部门:知识产权许可,通过许可其 DehydraTECH 技术来产生收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231223215953be07a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231223215953be07a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXX","LEXXW"],"gpt_icon":0},{"id":"2574468739","title":"Lexaria Bioscience Corp.盤中異動 臨近收盤股價大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574468739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574468739?lang=zh_tw&edition=fundamental","pubTime":"2025-10-11 03:48","pubTimestamp":1760125698,"startTime":"0","endTime":"0","summary":"北京时间2025年10月11日03时48分,Lexaria Bioscience Corp.股票出现波动,股价急速跳水5.78%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体跌幅为0.24%。其相关个股中,Quoin Pharmaceuticals Ltd、Protagonist Therapeutics, Inc.、Monte Rosa Therapeutics, Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Aditxt, Inc.、Cero Therapeutics Holdings, Inc.较为活跃,换手率分别为2259.89%、371.91%、131.35%,振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Protagonist Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为368.75%、41.02%、40.00%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp的专利药物输送技术DehydraTECH,通过促进更有效的口服输送,改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101103481894c2389f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101103481894c2389f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"gpt_icon":0},{"id":"2574169954","title":"Lexaria Bioscience Corp.盤中異動 早盤股價大漲5.53%報0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574169954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574169954?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 21:41","pubTimestamp":1760017289,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时41分,Lexaria Bioscience Corp.股票出现波动,股价大幅拉升5.53%。截至发稿,该股报0.960美元/股,成交量10.7087万股,换手率0.48%,振幅5.18%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体跌幅为0.28%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp的专利药物输送技术DehydraTECH,通过促进更有效的口服输送,改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009214130972541e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009214130972541e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"gpt_icon":0},{"id":"2570119045","title":"Lexaria Bioscience Corp.盤中異動 下午盤大幅上漲5.28%報1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570119045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570119045?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 03:01","pubTimestamp":1758826867,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日03时01分,Lexaria Bioscience Corp.股票出现波动,股价大幅拉升5.28%。截至发稿,该股报1.50美元/股,成交量11.5997万股,换手率0.59%,振幅8.72%。Lexaria Bioscience Corp.股票所在的生物技术行业中,整体跌幅为1.11%。Lexaria Bioscience Corp.公司简介:Lexaria Bioscience Corp的专利药物输送技术DehydraTECH,通过促进更有效的口服输送,改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092603010897a9cdf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092603010897a9cdf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}